Atlas Venture Fund Xi, L.p. - Net Worth and Insider Trading
Atlas Venture Fund Xi, L.p. Net Worth
The estimated net worth of Atlas Venture Fund Xi, L.p. is at least $437 Million dollars as of 2024-12-27. Atlas Venture Fund Xi, L.p. is the 10% Owner of Dyne Therapeutics Inc and owns about 8,050,704 shares of Dyne Therapeutics Inc (DYN) stock worth over $198 Million. Atlas Venture Fund Xi, L.p. is the 10% Owner of Day One Biopharmaceuticals Inc and owns about 8,984,019 shares of Day One Biopharmaceuticals Inc (DAWN) stock worth over $114 Million. Atlas Venture Fund Xi, L.p. is also the 10% Owner of Akero Therapeutics Inc and owns about 3,974,858 shares of Akero Therapeutics Inc (AKRO) stock worth over $113 Million. Besides these, Atlas Venture Fund Xi, L.p. also holds Third Harmonic Bio Inc (THRD) , Ikena Oncology Inc (IKNA) , Xilio Therapeutics Inc (XLO) . Details can be seen in Atlas Venture Fund Xi, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Atlas Venture Fund Xi, L.p. has not made any transactions after 2024-02-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Atlas Venture Fund Xi, L.p.
Atlas Venture Fund Xi, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Atlas Venture Fund Xi, L.p. owns 7 companies in total, including Dyne Therapeutics Inc (DYN) , Akero Therapeutics Inc (AKRO) , and Ikena Oncology Inc (IKNA) among others .
Click here to see the complete history of Atlas Venture Fund Xi, L.p.’s form 4 insider trades.
Insider Ownership Summary of Atlas Venture Fund Xi, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DYN | Dyne Therapeutics Inc | 2024-02-28 | 10 percent owner |
AKRO | Akero Therapeutics Inc | 2019-06-24 | 10 percent owner |
IKNA | Ikena Oncology Inc | 2021-12-14 | 10 percent owner |
2024-02-08 | 10 percent owner | ||
2022-06-17 | 10 percent owner | ||
2022-09-19 | 10 percent owner | ||
2023-11-03 | 10 percent owner |
Atlas Venture Fund Xi, L.p. Latest Holdings Summary
Atlas Venture Fund Xi, L.p. currently owns a total of 6 stocks. Among these stocks, Atlas Venture Fund Xi, L.p. owns 8,050,704 shares of Dyne Therapeutics Inc (DYN) as of February 28, 2024, with a value of $198 Million and a weighting of 45.35%. Atlas Venture Fund Xi, L.p. owns 8,984,019 shares of Day One Biopharmaceuticals Inc (DAWN) as of June 17, 2022, with a value of $114 Million and a weighting of 26.01%. Atlas Venture Fund Xi, L.p. also owns 3,974,858 shares of Akero Therapeutics Inc (AKRO) as of June 24, 2019, with a value of $113 Million and a weighting of 25.84%. The other 3 stocks Third Harmonic Bio Inc (THRD) , Ikena Oncology Inc (IKNA) , Xilio Therapeutics Inc (XLO) have a combined weighting of 2.8% among all his current holdings.
Latest Holdings of Atlas Venture Fund Xi, L.p.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DYN | Dyne Therapeutics Inc | 2024-02-28 | 8,050,704 | 24.63 | 198,288,840 |
DAWN | Day One Biopharmaceuticals Inc | 2022-06-17 | 8,984,019 | 12.66 | 113,737,681 |
AKRO | Akero Therapeutics Inc | 2019-06-24 | 3,974,858 | 28.42 | 112,965,464 |
THRD | Third Harmonic Bio Inc | 2022-09-19 | 594,096 | 10.62 | 6,306,329 |
IKNA | Ikena Oncology Inc | 2021-12-14 | 2,116,569 | 1.53 | 3,227,768 |
XLO | Xilio Therapeutics Inc | 2024-02-08 | 2,754,109 | 0.98 | 2,702,056 |
Holding Weightings of Atlas Venture Fund Xi, L.p.
Atlas Venture Fund Xi, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Atlas Venture Fund Xi, L.p. has made a total of 4 transactions in Dyne Therapeutics Inc (DYN) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Dyne Therapeutics Inc is the sale of 807,838 shares on February 28, 2024, which brought Atlas Venture Fund Xi, L.p. around $20 Million.
According to the SEC Form 4 filings, Atlas Venture Fund Xi, L.p. has made a total of 2 transactions in Day One Biopharmaceuticals Inc (DAWN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Day One Biopharmaceuticals Inc is the acquisition of 766,667 shares on June 17, 2022, which cost Atlas Venture Fund Xi, L.p. around $12 Million.
According to the SEC Form 4 filings, Atlas Venture Fund Xi, L.p. has made a total of 0 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years. The most-recent trade in Akero Therapeutics Inc is the acquisition of 270,000 shares on June 24, 2019, which cost Atlas Venture Fund Xi, L.p. around $4 Million.
More details on Atlas Venture Fund Xi, L.p.'s insider transactions can be found in the Insider Trading History of Atlas Venture Fund Xi, L.p. table.Insider Trading History of Atlas Venture Fund Xi, L.p.
- 1
Atlas Venture Fund Xi, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Atlas Venture Fund Xi, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Atlas Venture Fund Xi, L.p. is -5.92%. GuruFocus also compares Atlas Venture Fund Xi, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Atlas Venture Fund Xi, L.p. within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Atlas Venture Fund Xi, L.p.'s insider trading performs compared to the benchmark.
Performance of Atlas Venture Fund Xi, L.p.
Atlas Venture Fund Xi, L.p. Ownership Network
Atlas Venture Fund Xi, L.p. Owned Company Details
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Atlas Venture Fund Xi, L.p. is the 10 percent owner of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include See Remarks Richard William Scalzo , See Remarks Oxana Beskrovnaya , and director & 10 percent owner Dirk Kersten .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Atlas Venture Fund Xi, L.p. made 3 insider transaction in Dyne Therapeutics Inc (DYN) with a net sale of 1,818,779. Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 852,067 shares made by Dirk Kersten , a net sale of 280,316 shares made by Richard William Scalzo , and a net sale of 272,058 shares made by Susanna Gatti High .
In summary, during the past 3 months, insiders sold 548,859 shares of Dyne Therapeutics Inc (DYN) in total and bought 0 shares, with a net sale of 548,859 shares. During the past 18 months, 8,033,921 shares of Dyne Therapeutics Inc (DYN) were sold and 1,746,285 shares were bought by its insiders, resulting in a net sale of 6,287,636 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
Atlas Venture Fund Xi, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Atlas Venture Fund Xi, L.p.. You might contact Atlas Venture Fund Xi, L.p. via mailing address: 400 Technology Square, 10th Floor, Cambridge Ma 02139.